People dispensed fentanyl one or more times in a year, rate per 1,000

Description

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had fentanyl dispensed to them by a community pharmacy, by year (2019 to 2023). 

Rationale

Fentanyl is recommended for people with moderate to severe pain as an alternate option after morphine and depending on patient circumstances. 

Measure set
Health areas and conditions
Numerator

PHO-enrolled population who were dispensed fentanyl during the calendar year.

Numerator detail

Medication: 1274 fentanyl citrate; 3801 fentanyl; 3896 fentanyl citrate.

Numerator exclusions

People who were excluded from the analysis were: 

  • individuals with missing demographics– that is, those with no recorded value for one or more of the National Health Index (NHI) fields used to derive the demographic variables of interest (age, gender, ethnicity and district of domicile). For instance, a person with no recorded ethnicity in 2023 is excluded from all indicators for that calendar year. This approach ensures a consistent denominator throughout the analyses. 
  • those who weren’t enrolled in a PHO in the calendar year.  
Denominator

PHO-enrolled population during the calendar year 

Disaggregation

District analysis: By year (2019 –2023), age group (0–24, 25–64; 65–79 and 80 and over), gender (female, male), ethnic group (Māori, Pacific peoples, Asian and European/Other) and Health New Zealand district of domicile. 

PHO analysis: By year (2023), age group, gender, ethnic group, Primary Health Organisation (PHO) most recently enrolled with (for the relevant year), PHO group (small, medium, medium-large and large). 

Notes

People who were excluded from the analysis were:

  • individuals with missing demographics– that is, those with no recorded value for one or more of the National Health Index (NHI) fields used to derive the demographic variables of interest (age, gender, ethnicity and district of domicile). For instance, a person with no recorded ethnicity in 2023 is excluded from all indicators for that calendar year. This approach ensures a consistent denominator throughout the analyses.
  • those who weren’t enrolled in a PHO in the calendar year. 

Data is not presented where the number of people in the numerator was less than 10. This is to preserve confidentiality. 

Age group is assigned using 30 June of each calendar year as the cutoff point. For example, a person turning 65 years old on 30 June 2023 will be assigned to the 65–79 years age group for 2023, while a person turning 65 on 1 July 2023 will be assigned the 25–64 group for the same year.. 

Unlike other atlases, the Opioid Atlas includes individuals who died during the calendar year in all indicators. This is because opioid use is higher among older adults and those in the final stages of life, due to chronic conditions, pain management, and palliative care needs. Including them ensures a complete and accurate picture of opioid exposure.

See technical document for details

Measure methodology last updated
2018-2024
Reference period
2019-2023